Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen medication which is used in the treatment of prostate cancer. From Wikipedia
Analysts predict Novo Nordisk's diabetes drug will be included in the next round of Medicare price cuts under the Inflation Reduction Act.
